Diagnostic Yield of Comprehensive Reanalysis After Nondiagnostic Short-Read Genome Sequencing in Infants With Unexplained Epilepsy

Comprehensive reanalysis after nondiagnostic rapid genome sequencing has utility for infants with unexplained epilepsy. Our findings support implementation of reanalysis within 1-2 years after nondiagnostic genomic sequencing into routine clinical care of children with unexplained epilepsy and the expansion of clinically accredited genomic sequencing to include complex and noncoding variant detection.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2026-02-13
DOI
https://doi.org/10.1212/wnl.0000000000214645
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diagnostic Yield of Comprehensive Reanalysis After Nondiagnostic Short-Read Genome Sequencing in Infants With Unexplained Epilepsy

Lyndsey McRae, Paul De Fazio, Neta Pipko, Michael Yoong Yoong et al.
Neurology
Genomics and Rare Diseases
article

Diagnostic Yield of Comprehensive Reanalysis After Nondiagnostic Short-Read Genome Sequencing in Infants With Unexplained Epilepsy

Lyndsey McRae, Paul De Fazio, Neta Pipko, Michael Yoong Yoong, P. M. Lombard, Brian J. McCabe, Armando Caballero, Natalie Jane Chandler, Brett Trost, Jenny Nguyen, Marios Kaliakatsos, Puneet Jain, Jane Hassell, Lacey Smith, Sarah Mulhern, White Sm, Elizabeth Scotchman, Alissa Maria D'Gama, Wanqing Shao, Vann Chau, Emma Wakeling, Amy McTague, Ashley J. Pritchard, Sarah E.M. Stephenson, Annapurna Poduri, J. Helen Cross, Catherine Marx, Edward J. Higginbotham, Nicole S.Y. Liang, Katherine B. Howell, John Christodoulou, Lyn S. Chitty, Maria Lachgar-Ruiz, Anna J.S. Griffiths, Ingrid E. Scheffer, Ashish R. Deshwar, Christin Eltze, Matthew Coleman, Ben Paternoster, Jashanpreet Sidhu, Christian R. Marshall, John Coleman
article en

Abstract

Comprehensive reanalysis after nondiagnostic rapid genome sequencing has utility for infants with unexplained epilepsy. Our findings support implementation of reanalysis within 1-2 years after nondiagnostic genomic sequencing into routine clinical care of children with unexplained epilepsy and the expansion of clinically accredited genomic sequencing to include complex and noncoding variant detection.

NeurologyVol. 106(6)
Boston Children's Hospital (US), Royal Children's Hospital (AU), Harvard University (US), The University of Melbourne (AU), University of Toronto (CA), Florey Institute of Neuroscience and Mental Health (AU), Great Ormond Street Hospital (GB), Great Ormond Street Hospital for Children NHS Foundation Trust (GB), Royal London Hospital (GB), Hospital for Sick Children (CA), Victorian Clinical Genetics Services (AU), SickKids Foundation (CA), Murdoch Children's Research Institute (AU), Boston Children's Museum (US), Royal London Hospital for Integrated Medicine (GB), Austin Health (AU), University College London (GB)
Openalex Percentile: Top 54%
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.